Preliminary study for the preparation of fatty acid bioconjugated L-asparaginase micellar nanocarrier as a delivery system for peptide anti-cancer agents

  • سال انتشار: 1399
  • محل انتشار: فصلنامه تحقیقات جاری در داروسازی، دوره: 6، شماره: 3
  • کد COI اختصاصی: JR_TIPS-6-3_004
  • زبان مقاله: انگلیسی
  • تعداد مشاهده: 406
دانلود فایل این مقاله

نویسندگان

Hajar Ashrafi

Department of pharmaceutics, school of pharmacy, Shiraz university of medical sciences, Shiraz, Iran

amir Azadi

Department of Pharmaceutics, school of Pharmacy, Siraz University of Medical Sciences, Shiraz, Iran

Soliman Mohammadi-Samani

Department of Pharmaceutics, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.

Younes Ghasemi

Department of Pharmaceutical Biotechnology, School of Pharmacy and Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

Saeid** Daneshamouz

Department of Pharmaceutics, School of Pharmacy and Pharmaceutical Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

چکیده

In the present study, the mixing behavior of different groups of surfactants and fatty acid bioconjugated L-asparaginase investigated. The amphiphilic macromolecules were achieved by covalent linkage of fatty acids with different chain lengths (C12, C16, and C22) to the native enzyme, L-asparaginase. The amino group of L-asparaginase lysine residue was conjugated to the carboxylic group of fatty acids, using a carbodiimide activator. The effect of different kinds of surfactants on particle size and enzyme activity of fatty acid bioconjugated L-ASNase was evaluated. The particle sizes of resulted micellar nanocarrier before and after lyophilization and enzyme activity investigated. Among all surfactants, pluronic F-127 with fatty acid bioconjugated L-asparaginase presented more plasma and PBS half-life. Higher activity value after lyophilization for bioconjugate with pluronic F-127 also achieved. These findings from L-asparaginase modification by fatty acid and surfactants indicate a promising stabilized product that may serve as a new candidate for medical purposes.

کلیدواژه ها

L-asparaginase, Lipid-protein conjugation, micellar nanocarrier, Pluronic F-127

اطلاعات بیشتر در مورد COI

COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.

کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.